Editorial: direct-acting antivirals significantly improve quality of life in patients with hepatitis C virus infection.

about

Editorial: direct-acting antivirals significantly improve quality of life in patients with hepatitis C virus infection.

Item

http://www.wikidata.org/entity/Q47552560

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Editorial: direct-acting antiv ...... h hepatitis C virus infection.

@en

Editorial: direct-acting antiv ...... h hepatitis C virus infection.

@nl

type

Item

label

Editorial: direct-acting antiv ...... h hepatitis C virus infection.

@en

Editorial: direct-acting antiv ...... h hepatitis C virus infection.

@nl

prefLabel

Editorial: direct-acting antiv ...... h hepatitis C virus infection.

@en

Editorial: direct-acting antiv ...... h hepatitis C virus infection.

@nl

P1476

Editorial: direct-acting antiv ...... h hepatitis C virus infection.

@en

P2093

M Danta

http://www.w3.org/2001/XMLSchema#string

S Sanagapalli

http://www.w3.org/2001/XMLSchema#string

P2860

The patient's journey with chronic hepatitis C from interferon plus ribavirin to interferon- and ribavirin-free regimens: a study of health-related quality of life.

Understanding real-world adherence in the directly acting antiviral era: A prospective evaluation of adherence among people with a history of drug use at a community-based program in Toronto, Canada.

An In-Depth Analysis of Patient-Reported Outcomes in Patients With Chronic Hepatitis C Treated With Different Anti-Viral Regimens.

Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy.

Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation.

Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3.

Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition.

Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group.

P304

536-537

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1111/APT.14467

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Santosh Sanagapalli

M Danta

P577

2018-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29341280

http://www.w3.org/2001/XMLSchema#string